Growth Hormone & Performance
IGF-1
Last updated
Dosing on file unverified
SC: 40-120 mcg/kg BID (escalating); SC: 10-20 mg/day; IV: 1-4 mg/kg single dose
Carried from a source that labels it unverified, and reproduced with that label attached. A record of what is reported, not a recommendation. No citation on this page establishes it.
Literature on file 8
-
human observational
Serum insulin-like growth factor-1 concentrations are not reduced in Pomeranian dogs with Alopecia X: a case-control study. graded on: an observational human design — “case-control”
-
human observational
NCT00673309: Assessment of Mechanisms of Improved Wound Healing of Anabolic Agents and Diet in Severely Burned Patients graded on: a registered clinical study — “clinicaltrials.gov”
-
human observational
NCT01207908: IGF-1 Therapy and Muscle Function in Duchenne Muscular Dystrophy graded on: a registered clinical study — “clinicaltrials.gov”
-
human observational
NCT01525901: A Double-Blind Placebo-Controlled Crossover Trial of Insulin-Like Growth Factor-1 (IGF-1) in Children and Adolescents With 22q13 Deletion Syndrome(Phelan-McDermid Syndrome) graded on: a registered clinical study — “clinicaltrials.gov”
-
human observational
NCT00330668: Recombinant Human Insulin-Like Growth Factor-1 (IGF-1) Treatment of Children With Growth Failure Associated With Primary IGF-1 Deficiency: An Open-Label, Multi-Center, Extension Study graded on: a registered clinical study — “clinicaltrials.gov”
-
human observational
NCT00684957: Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors in Adult Patients With Growth Hormone Deficiency graded on: a registered clinical study — “clinicaltrials.gov”
Not graded
2 citations whose study design could not be read from the title. Left ungraded rather than guessed at.
- not graded
- not graded
Identity
- UniProt
- P01343
- Sequence
- GPETLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA
Caveat on these identifiers
P01343 is a secondary accession; the active UniProt entry for human IGF-1 is P05019.
Notes unverified prose
Human trials: 40-120 mcg/kg SC; 10-20 mg/day SC; 1-4 mg/kg IV (fusion protein); Human SC/IV trials; Phase 2 ARPEGGIO (scp776)
Not on file 7
7 of the 8 fields we track hold nothing on this record, and each says why. A blank field is a bug; a named absence is a finding.
- molecular weightnothing we hold supplies it
- molecular formulanothing we hold supplies it
- CAS registry numbernothing we hold supplies it
- PubChem identifiernothing we hold supplies it
- SMILES stringnothing we hold supplies it
- InChInothing we hold supplies it
- InChI keynothing we hold supplies it
Each field links to every other record missing the same thing. The full ledger holds 521 gaps across 136 records.